查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1733298

全球私人诊所实验​​室市场：市场规模（按产品、应用和地区划分）、未来预测

Global Office Based Lab Market Size By Product (Single-specialty OBL, Multi-specialty OBL, Hybrid), By Application (Vascular Surgery, Ophthalmology, Pain Management), By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

私人诊所实验​​室的市场规模与预测

2024 年基于医生的实验室市场规模价值 112 亿美元，预计到 2032 年将达到 172 亿美元，预测期内（2026-2032 年）的复合年增长率为 6.75%。

临床环境中外科手术的上升趋势和各种血管疾病的发生率上升正在推动全球基于医生的实验室市场的发展。推动全球市场扩张的其他关键方面是增加报销、成本优势和患者便利性。此外，人们对微创手术的偏好和采用日益增加，预计将打开全球市场。全球范围内目标疾病盛行率的上升、对微创手术的偏好和采用的增加、以及医生在为患者提供治疗方面的自主性水平的提高都是影响基于医生的实验室市场的主要因素。私人诊所实验​​室顺畅的业务流程和较高的患者满意度可能会提供进一步的市场成长潜力。

定义全球私人诊所实验​​室市场

私人诊所实验​​室是配备各种医疗设备和技术的专科诊所或医生办公室，为患者提供个人化护理。它也被称为门诊手术中心。它有助于在短暂的住院时间内提供快速治疗。它使医生能够更好地控制患者，从而提高生产力和效率。全球目标疾病盛行率的上升、对微创手术的偏好和适应症的增加以及医生在为患者群体提供治疗方面的控制力和自主权的增强是影响基于医生的实验室市场增长的主要因素。

私人诊所实验​​室的顺畅营运流程和较高的患者满意度预计将为市场成长提供进一步的机会。以从业人员为基础的实验室市场依模式分为单一实验室、多专业实验室和混合实验室。基于医生的实验室市场根据服务分为週边血管护理、血管内护理、心臟病学、介入放射学、静脉等。诊断测试、动脉粥状硬化斑块切除动脉粥状硬化斑块切除术、血栓切除术、栓塞治疗、血管内超音波(IVUS)、血液透析机晶粒以及下腔静脉过滤器的放置和移除都是血管内干预的例子。

血管成形术和支架置入术是两种不同类型的心血管手术。静脉手术包括静脉消融、中心静脉治疗和深层静脉栓塞症(DVT) 手术。心血管外科医生、眼科医生、疼痛管理医师、胃肠病学家、经皮心臟科医生、介入放射科医生和骨科医生是私人诊所实验​​室市场中的一些专家。 OBL 产业采用人工智慧对于技术创新至关重要，而由于人工智慧和机器人手术趋势的变化，私人诊所实验​​室市场将显着成长。因此，这是最近受到广泛关注的重要领域。

全球私人诊所实验​​室市场概况

推动对 OBL 需求的主要驱动因素之一是门诊手术趋势的增加以及各种血管疾病盛行率的上升。此外，预计该行业将蓬勃发展，患者满意度高，专业团队专注。许多服务供应商遍布全国，包括 Nationwide Cardiac Associates、Envision Healthcare 和 Surgery Partners，为患者提供低成本、基于医生的手术产品和解决方案。

此外，飞利浦医疗、西门子赫兹等领先製造商也与医生合作设立OBL，为他们的实验室配备必要的设备，提供从头到尾的全面解决方案。与医院门诊 (HO) 相比，OBL 的建立为医生提供了支付方面的优势。由于私人诊所的实验室为医生提供丰厚的报销，因此进行血管手术的费用较低。此外，预计该行业将蓬勃发展，患者满意度高，专业团队专注。全国有许多服务供应商，包括 National Cardiac Partners、Envision Health 和 Surgery Partners，为患者提供低成本、以医生为基础的手术服务和解决方案。

然而，OBL 在实施新技术时担心的一个问题是报销。医疗保险和医疗补助服务中心 (CMS) 为程序设定付款标准，保险公司遵循这些标准。此外，由于研发成本，新设备和技术价格昂贵。 OBL 的预算非常紧张，因为其在技术方面获得的补偿比医院少。 OBL 要继续经营，就无法负担新设备的高昂成本。因此，核准用于门诊病人的设备可能价格过高，并且未充分利用。

私人诊所实验​​室市场（按产品）

  • 单一主体 OBL
  • 多主体 OBL
  • 杂交种
  • 根据产品，市场细分为单一主题 OBL、多主题 OBL 和混合。虽然单一专业的 OBL 在 2018 年占据了市场主导地位，但预计混合从业人员实验室将在未来几年快速成长。单一专业实验室能够提供更好的以患者为中心的护理，而混合实验室则透过将不同的服务整合在同一屋檐下，从而提供更高的盈利。

私人诊所实验​​室市场（按应用）

  • 血管外科
  • 眼科
  • 疼痛管理
  • 胃肠病学
  • 整形外科
  • 其他的
  • 根据应用，市场分为血管外科、眼科、疼痛管理、胃肠病学、整形外科等。血管外科医生是 OBL 中最常见的服务供应商，占据了很大的市场份额。这可能是由于该国血管疾病负担日益加重所致。血管外科医师在私人诊所进行所有主要的血管手术，包括主动脉、肠系膜、肾臟、锁骨下、髂股、胫骨和脚部手术。

私人诊所实验​​室市场（按地区）

  • 北美洲
  • 欧洲
  • 亚太地区
  • 世界其他地区
  • 根据地区，全球基于实践的实验室市场分为北美、欧洲、亚太地区和亚太其他地区。从服务来看，由于美国动脉硬化发病率不断上升，週边血管介入（PVI）占据私人诊所实验​​室市场主导地位。此外，大量针对动脉和静脉阻塞患者进行的球囊血管成形术和支架置入术也推动了这一领域的成长。美国近 70% 的外科手术是在门诊进行的，约 25% 的外科手术是在医生检查室进行的。

主要企业

「全球私人诊所实验​​室市场」分析报告提供了有关 Envision Healthcare、TH Medical、MEDNAX Services, Inc、TeamHealth、Medical Facilities Corporation、Surgical Care Affiliates、QHCCS, LLC、Fresenius Medical Care AG &Co.KGaA、Surgery Partners、Medical Facilities Corporation 等公司的宝贵资讯。竞争格局部分还包括上述全球公司的关键发展策略、市场占有率和市场排名分析。

主要进展

  • 波士顿科学公司以 42 亿美元收购英国微创设备製造商 BTG，将扩大其微创手术设备产品组合。两家公司于 2018 年 11 月达成收购协议，波士顿科学公司预计此次收购将支持其患者照护策略。
  • 豆蔻去年获得 FDA核准后被圣犹达以 3.75 亿美元收购。该设备的表面积只有回形针大小，它使用最初用于监测喷射引擎的嵌入式感测器来远端监测心臟衰竭患者的肺动脉张力。圣犹达医疗公司致力于“基于创新的成长策略”，提供医疗设备，帮助医生治疗患有慢性心血管疾病的患者。
  • 今年早些时候，波士顿科学公司收购了无线心臟监测设备製造商 Preventive Solutions 27% 的股份。根据协议，波士顿科学公司将成为 Preventive 心臟监测产品的全球行销商和经销商。

目录

第一章 全球私人诊所市场简介

  • 市场概览
  • 分析范围
  • 先决条件

第二章执行摘要

第三章 已验证的市场研究分析方法

  • 资料探勘
  • 验证
  • 第一手资料
  • 资料来源列表

第四章全球私人诊所市场展望

  • 概述
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 波特五力模型
  • 价值链分析

第五章全球私人诊所实验​​室市场（按产品划分）

  • 概述
  • 单一主体 OBL
  • 多主体 OBL
  • 杂交种

6. 全球私人诊所实验​​室市场（按应用）

  • 概述
  • 血管外科
  • 眼科
  • 疼痛管理
  • 胃肠病学
  • 整形外科
  • 其他的

7. 全球私人诊所实验​​室市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 世界其他地区
    • 拉丁美洲
    • 中东和非洲

8. 全球私人诊所实验​​室市场的竞争格局

  • 概述
  • 各公司市场排名
  • 主要发展策略

第九章 公司简介

  • Envision Healthcare
  • TH Medical
  • MEDNAX Services, Inc.
  • TeamHealth
  • Medical Facilities Corporation
  • Surgical Care Affiliates
  • QHCCS, LLC
  • Fresenius Medical Care AG & Co. KGaA
  • Surgery Partners
  • Medical Facilities Corporation

第十章 附录

  • 相关分析
简介目录
Product Code: 63577

Office Based Lab Market Size And Forecast

Office Based Lab Market size was valued at USD 11.2 Billion in 2024 and is projected to reach USD 17.2 Billion by 2032, growing at a CAGR of 6.75% during the forecast period 2026-2032.

The growing trend of performing surgical techniques in clinical settings, as well as the rising frequency of various vascular illnesses, are driving the global Office Based Lab Market. Other major aspects driving global market expansion are higher reimbursements, expense advantages, and patient convenience. Furthermore, the global market is predicted to develop because of an increase in the inclination for and implementation of minimally invasive surgeries The rise in the prevalence of target diseases around the world, rising preferences for and adoption of minimally invasive surgeries, and increased levels of autonomy for doctors in providing therapies to their patients are all major factors that will influence the market for office-based labs. Smooth operational flow at office-based labs, as well as a high patient satisfaction rate, will give further market growth potential.

Global Office Based Lab Market Definition

Office-based labs are specialized clinics or physician offices that are outfitted with various medical devices and technologies in order to provide patients with personalized care. They are also known as ambulatory surgical centers. They are useful for providing swift treatments with a shorter stay time. They give physicians more control over their patients and, as a result, promote good productivity and efficiency. The rising incidence of target diseases globally, soaring preferences and adaptation of minimally invasive surgeries, and greater control and autonomy for doctors in supplying therapies to their patient populations are the major factors influencing the growth of the Office Based Lab Market.

A smooth operational flow at office-based labs and a high patient satisfaction rate will provide additional opportunities for market growth. The market for Office Based Lab is classified into single labs, multi-specialty labs, and hybrid labs based on modality. The Office Based Lab Market is divided as peripheral vascular treatment, endovascular treatments, cardiology, interventional radiology, venous, and other segments based on service. Diagnostic testing, atherectomy, thrombectomy, embolization, intravascular ultrasound (IVUS), hemodialysis access dicots, and IVC filter implantation and removal are all examples of endovascular interventions.

Angioplasty and stenting are two different types of cardiac procedures. Venous procedures include venous ablation, central venous treatments, and deep vein thrombosis (DVT) procedures. Cardiovascular surgeons, ophthalmology, pain control, gastro, percutaneous cardiologists, interventional radiologists, orthopedics, and others are among the specialists in the Office Based Lab Market. Artificial intelligence's adoption in the OBL industry is critical for innovation, as in the Office Based Lab Market there has been a significant increase because of artificial intelligence and the shift in the trend toward robotic surgery. Thus, it is a key area that has been given key attention lately.

Global Office Based Lab Market Overview

One of the key causes driving the desire for Office Based Lab (OBL) is the growing tendency of surgical operations to be conducted in outpatient settings, as well as the rising incidence of different vascular diseases. Furthermore, the industry is predicted to develop due to high patient satisfaction and a concentrated and dedicated team of experts. Many service providers, such as Nationwide Cardiac Associates, Envision Healthcare, and Surgery Partners, are located around the country and have been providing patients with low-cost office-based surgical products and solutions.

Moreover, major manufacturers such as Philips Healthcare and Siemens Healthineers have formed collaborations with physicians to set up OBLs, equip laboratories with necessary devices, and provide comprehensive solutions from start to finish, which is projected to drive market expansion. Establishing an OBL is advantageous for physicians in terms of payments as compared to hospital outpatient (HO) settings. Because of the substantial reimbursement offered to physicians, the cost of vascular operations conducted in office-based laboratories is lower. Furthermore, the industry is predicted to develop due to high patient satisfaction and a concentrated and dedicated team of experts. Many service providers, such as National Cardiac Partners, Envision Health, and Surgery Partners, are located around the country and have been offering patients low-cost office-based surgical services and solutions.

However, reimbursement is a concern for the OBL when it comes to new technology. The Centers for Medicare & Medicaid Services (CMS) sets a standard for procedure payments, and insurers follow suit. New equipment and technologies are also more expensive, owing to the costs of research and development. Because compensation for the technical element is lower for OBLs than for hospitals, they operate on a tighter budget. OBLs simply cannot afford the expensive costs of new devices in order to stay in business. As a result, equipment approved for outpatient usage may be prohibitively expensive and consequently underutilized.

Office Based Lab Market, By Product

  • Single-specialty OBL
  • Multi-specialty OBL
  • Hybrid
  • Based On Product, The Market is Segmented into Single-specialty OBL, Multi-specialty OBL, And Hybrid. Single specialty OBLs dominated the market in 2018, but hybrid office-based labs are expected to rise rapidly over the next few years. Single-specialty laboratories provide better patient-centered care, but hybrid labs provide greater profitability by combining different services under one roof.

Office Based Lab Market, By Application

  • Vascular Surgery
  • Ophthalmology
  • Pain Management
  • Gastroenterology
  • Orthopedics
  • Others
  • Based On Application, The Market is Segmented into Vascular Surgery, Ophthalmology, Pain Management, Gastroenterology, Orthopedics, And Others. Vascular surgeons are the most common service providers in OBLs, with a large percentage of the market. This can be attributable to the country's expanding vascular disease burden. Vascular surgeons undertake all major vascular procedures in office settings, including aortic, mesenteric, kidney, subclavian, iliofemoral, tibial, or pedal.

Office Based Lab Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of Geography, The Global Office Based Lab Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. Because of the increased proportion of arteriosclerosis in the United States, peripheral vascular treatments (PVI) dominated the Office Based Lab Market by service. Segment growth has also been assisted by a large number of balloon angioplasty and stenting treatments performed in patients with blocked arteries and veins. Nearly 70% of surgical procedures in the United States are conducted in outpatient settings, with around 25% performed in a doctor's office.

Key Players

The "Global Office Based Lab Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as Envision Healthcare, TH Medical, MEDNAX Services, Inc., TeamHealth, Medical Facilities Corporation, Surgical Care Affiliates, QHCCS, LLC, Fresenius Medical Care AG & Co. KGaA, Surgery Partners, Medical Facilities Corporation, and others. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

  • With the acquisition of British minimally invasive device producer BTG for $4.2 billion, Boston Scientific is expected to extend its portfolio of minimally invasive surgical equipment. In November 2018, the two businesses reached an agreement for the acquisition, with Boston Scientific expecting the deal to assist its patient-care strategy.
  • Cardamoms was purchased for $375 million by St. Jude after it received FDA approval last year. The device is really about the surface area of a paper clip as well as uses Embedded sensors originally capable of monitoring jet engines to remotely monitor a heart failure patient's pulmonary artery tension. St. Jude Medical has been working on an "innovation-based growth strategy" that will enable it to offer a wide range of associated with medical devices to help doctors treat patients with chronic cardiovascular disease.
  • Boston Scientific purchased a 27 percent stake in Preventive Solutions, a maker of wireless heart-monitoring devices, earlier this year. As a result of the agreement, Boston Sci will be Preventive's official global marketing and sales representative for cardiac patient monitoring products.

TABLE OF CONTENTS

1 INTRODUCTION TO GLOBAL OFFICE BASED LAB MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL OFFICE BASED LAB MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL OFFICE BASED LAB MARKET, BY PRODUCT

  • 5.1 Overview
  • 5.2 Single-specialty OBL
  • 5.3 Multi-specialty OBL
  • 5.4 Hybrid

6 GLOBAL OFFICE BASED LAB MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Vascular Surgery
  • 6.3 Ophthalmology
  • 6.4 Pain Management
  • 6.5 Gastroenterology
  • 6.6 Orthopedics
  • 6.7 Others

7 GLOBAL OFFICE BASED LAB MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Latin America
    • 7.5.2 Middle East and Africa

8 GLOBAL OFFICE BASED LAB MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 Envision Healthcare
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 TH Medical
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 MEDNAX Services, Inc.
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 TeamHealth
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 Medical Facilities Corporation
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 Surgical Care Affiliates
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Developments
  • 9.7 QHCCS, LLC
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments
  • 9.8 Fresenius Medical Care AG & Co. KGaA
    • 9.8.1 Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Outlook
    • 9.8.4 Key Developments
  • 9.9 Surgery Partners
    • 9.9.1 Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Outlook
    • 9.9.4 Key Developments
  • 9.10 Medical Facilities Corporation
    • 9.10.1 Overview
    • 9.10.2 Financial Performance
    • 9.10.3 Product Outlook
    • 9.10.4 Key Developments

10 Appendix

  • 10.1 Related Research